Malcolm Hill
16Patents
7h-index
15Co-inventors
63Inventor score
Filing activity: Jul 9, 1982 → Mar 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6116237A | Methods of dry powder inhalation | Human Necessities | 129 | Expired |
| US6060069A | Pulmonary delivery of pharmaceuticals | Human Necessities | 104 | Expired |
| USD280661S | Blower | General | 19 | Expired |
| US9782347B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 13 | Active |
| US10176301B2 | Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis | Physics | 12 | Active |
| US8497258B2 | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 12 | Active |
| US10272037B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 12 | Active |
| US9119863B2 | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 7 | Active |
| US8865692B2 | Compositions for the treatment of gastrointestinal inflammation | Human Necessities | 5 | Active |
| US9050368B2 | Corticosteroid compositions | Human Necessities | 5 | Active |
| US10640812B2 | Processes for the production of oligonucleotides | Physics | 2 | Active |
| US12275983B2 | Processes for the production of oligonucleotides | Physics | 0 | Active |
| US11357859B2 | Compositions for the treatment of gastrointestinal inflammation | Human Necessities | 0 | Active |
| US11197822B2 | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 0 | Active |
| US10293052B2 | Compositions for the treatment of gastrointestinal inflammation | Human Necessities | 0 | Active |
| US11413296B2 | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.